Research — CTCELLS | 씨티셀즈

Literature

Cytokine engineered NK-92 therapy to improve persistence and anti-tumor activity

Theranostics 2023; 13(5):1506-1519. doi:10.7150/thno.79942

Lossless Immunocytochemistry Based on Large-Scale Porous Hydrogel Pellicle for Accurate Rare Cell Analysis

ACS Appl. Mater. Interfaces 2023, 15, 12, 15059–15070 doi:10.1021/acsami.2c18321

Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation

Theranostics 2022; 12(8):3676-3689. doi:10.7150/thno.72511

An electroceutical approach enhances myelination via upregulation of lipid biosynthesis in the dorsal root ganglion

Biofabrication, Volume 14, Number 1, doi:10.1088/1758-5090/ac457c

Development of an antibody-like T-cell engager based on VH-VL heterodimer formation and its application in cancer therapy

Biomaterials Volume 271, doi:10.1016/j.biomaterials.2021.120760

Pipeline

CTCELLS Pipeline Graphic